Scuvée-Moreau Jacqueline, Boland Andre, Graulich Amaury, Van Overmeire Lionel, D'hoedt Dieter, Graulich-Lorge Fabienne, Thomas Elizabeth, Abras Aude, Stocker Martin, Liégeois Jean-Francois, Seutin Vincent
Research Center for Cellular and Molecular Neurobiology and Laboratory of Pharmacology, University of Liège, B-4000 Liège, Belgium.
Br J Pharmacol. 2004 Nov;143(6):753-64. doi: 10.1038/sj.bjp.0705979. Epub 2004 Oct 25.
We have recently shown that the alkaloid methyl-laudanosine blocks SK channel-mediated afterhyperpolarizations (AHPs) in midbrain dopaminergic neurones. However, the relative potency of the compound on the SK channel subtypes and its ability to block AHPs of other neurones were unknown. Using whole-cell patch-clamp experiments in transfected cell lines, we found that the compound blocks SK1, SK2 and SK3 currents with equal potency: its mean IC(50)s were 1.2, 0.8 and 1.8 microM, respectively. IK currents were unaffected. In rat brain slices, methyl-laudanosine blocked apamin-sensitive AHPs in serotonergic neurones of the dorsal raphe and noradrenergic neurones of the locus coeruleus with IC(50)s of 21 and 19 microM, as compared to 15 microM in dopaminergic neurones. However, at 100 microM, methyl-laudanosine elicited a constant hyperpolarization of serotonergic neurones of about 9 mV, which was inconsistently (i.e. not in a reproducible manner) antagonized by atropine and hence partly due to the activation of muscarinic receptors. While exploring the pharmacology of related compounds, we found that methyl-noscapine also blocked SK channels. In cell lines, methyl-noscapine blocked SK1, SK2 and SK3 currents with mean IC(50)s of 5.9, 5.6 and 3.9 microM, respectively. It also did not block IK currents. Methyl-noscapine was slightly less potent than methyl-laudanosine in blocking AHPs in brain slices, its IC(50)s being 42, 37 and 29 microM in dopaminergic, serotonergic and noradrenergic neurones, respectively. Interestingly, no significant non-SK effects were observed with methyl-noscapine in slices. At a concentration of 300 microM, methyl-noscapine elicited the same changes in excitability in the three neuronal types than did a supramaximal concentration of apamin (300 nM). Methyl-laudanosine and methyl-noscapine produced a rapidly reversible blockade of SK channels as compared with apamin. The difference between the IC(50)s of apamin (0.45 nM) and methyl-laudanosine (1.8 microM) in SK3 cells was essentially due to a major difference in their k(-1) (0.028 s(-1) for apamin and >or=20 s(-1) for methyl-laudanosine). These experiments demonstrate that both methyl-laudanosine and methyl-noscapine are medium potency, quickly dissociating, SK channel blockers with a similar potency on the three SK subtypes. Methyl-noscapine may be superior in terms of specificity for the SK channels.
我们最近发现生物碱甲基劳丹碱可阻断中脑多巴胺能神经元中SK通道介导的超极化后电位(AHPs)。然而,该化合物对SK通道亚型的相对效力及其阻断其他神经元AHPs的能力尚不清楚。通过在转染细胞系中进行全细胞膜片钳实验,我们发现该化合物以相同效力阻断SK1、SK2和SK3电流:其平均半数抑制浓度(IC50)分别为1.2、0.8和1.8微摩尔。IK电流未受影响。在大鼠脑片中,甲基劳丹碱阻断中缝背核5-羟色胺能神经元和蓝斑去甲肾上腺素能神经元中对蜂毒明肽敏感的AHPs,其IC50分别为21和19微摩尔,而在多巴胺能神经元中为15微摩尔。然而,在100微摩尔时,甲基劳丹碱引起5-羟色胺能神经元持续约9毫伏的超极化,阿托品对其拮抗作用不一致(即不可重复),因此部分是由于毒蕈碱受体的激活。在探索相关化合物的药理学时,我们发现甲基那可丁也能阻断SK通道。在细胞系中,甲基那可丁阻断SK1、SK2和SK3电流,其平均IC50分别为5.9、5.6和3.9微摩尔。它也不阻断IK电流。甲基那可丁在阻断脑片中的AHPs方面效力略低于甲基劳丹碱,其在多巴胺能、5-羟色胺能和去甲肾上腺素能神经元中的IC50分别为42、37和29微摩尔。有趣的是,在脑片中未观察到甲基那可丁有明显的非SK效应。在300微摩尔浓度下,甲基那可丁在三种神经元类型中引起的兴奋性变化与最大浓度的蜂毒明肽(300纳摩尔)相同。与蜂毒明肽相比,甲基劳丹碱和甲基那可丁对SK通道产生快速可逆的阻断。蜂毒明肽(0.45纳摩尔)和甲基劳丹碱(1.8微摩尔)在SK3细胞中的IC50差异主要源于它们k(-1)的显著差异(蜂毒明肽为0.028秒(-1),甲基劳丹碱≥20秒(-1))。这些实验表明,甲基劳丹碱和甲基那可丁都是中等效力、快速解离的SK通道阻滞剂,对三种SK亚型的效力相似。甲基那可丁在SK通道特异性方面可能更具优势。